Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Townsend Richard Nolan sold 3,295 Lexeo Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 3,295 Lexeo Therapeutics, Inc. shares at US$3.26 for US$10,742, leaving 373,483 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 3,295 shares
- Price
- US$3.26
- Value
- US$10,742
- Holding after
- 373,483 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 3,295 | US$3.26 | 373,483 | Direct |
Source
Download original · View original at SEC
Related
- Lexeo Therapeutics, Inc.
- Townsend Richard Nolan
- Lexeo Therapeutics, Inc. shareholders
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Aug 19, 2026
- Form 4 · Townsend Richard Nolan · Jul 1, 2026
- Form 4 · Townsend Richard Nolan · May 20, 2026
- Form 4 · Townsend Richard Nolan · Apr 7, 2026
- Form 4 · Tamayo Louis Edward · Nov 18, 2026
- Form 4 · Otero Jose Manuel · Nov 18, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Nov 16, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026